EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Value of the clinical pharmacist interventions in the application of the American College of Cardiology (ACC/AHA) 2018 guideline for cholesterol management

Mohammad M AlAhmad iD, Sham ZainAlAbdin, Khozama AlAhmad, Iqbal AlAhmad, Salah AbuRuz

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0283369 ↗

Kurz gefasst

Leitlinie in der Zeitschrift PLOS ONE, 2023. Verfasst von Mohammad M AlAhmad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, College of Pharmacy, Al Ain University, Al Ain, United Arab Emirates. Hauptthemen laut MEDLINE: Hypercholesterolemia, Cardiovascular Diseases, Cardiology, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The study aims to examine the extent to which the updated ACC/AHA management of blood cholesterol guideline (2018) is implemented in practice and to assess the value of the clinical pharmacist interventions in improving physicians’ adherence the guidelines recommendations.

Methods

We utilized in this study an interventional before-after design. The study was conducted on 272 adult patients who visited the study site internal medicine clinics and were candidates for statin therapy based on the 2018 ACC/AHA guidelines for cholesterol management. Adherence to guideline recommendations was measured before and after clinical pharmacists’ interventions by calculating the percentage of patients receiving statin therapy as per guideline recommendation, the type and intensity (moderate or high intensity) of statin therapy used, and the need for additional non-statin therapy.

Results

Adherence with guideline recommendations was significantly improved from 60.3% to 92.6% (X2 = 79.1, p = 0.0001) after clinical pharmacist interventions. Among patients who were on statin therapy, the percentage of those who were on proper statin intensity increased significantly from 47.6% to 94.4% (X2 = 72.5, p = 0.0001). The combination of statins with non-statin therapies such as ezetimibe and PCSK9 inhibitors increased from 8.5% to 30.6% (X2 = 95, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypercholesterolemiaCardiovascular DiseasesCardiologyHydroxymethylglutaryl-CoA Reductase InhibitorsAdultHumansUnited StatesProprotein Convertase 9PharmacistsCholesterolGuideline Adherence

Substanzen

PCSK9 protein, humanProprotein Convertase 9CholesterolHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, College of Pharmacy, Al Ain University, Al Ain, United Arab Emirates.
  • AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi, United Arab Emirates.
  • Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
  • Mediclinic AlAin Hospital, Al Ain, United Arab Emirates.
  • Czech Rehabilitation Hospital, Al Ain, United Arab Emirates.
  • Department of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, University of Jordan, Amman, Jordan.

ORCID-Profile: Mohammad M AlAhmad

Zitieren

APA

AlAhmad, M. M., ZainAlAbdin, S., AlAhmad, K., AlAhmad, I., & AbuRuz, S. (2023). Value of the clinical pharmacist interventions in the application of the American College of Cardiology (ACC/AHA) 2018 guideline for cholesterol management. PLOS ONE. https://doi.org/10.1371/journal.pone.0283369

Vancouver

AlAhmad MM, ZainAlAbdin S, AlAhmad K, AlAhmad I, AbuRuz S. Value of the clinical pharmacist interventions in the application of the American College of Cardiology (ACC/AHA) 2018 guideline for cholesterol management. PLOS ONE. 2023. doi:10.1371/journal.pone.0283369

BibTeX
@article{AlAhmad2023,
  author = {AlAhmad, Mohammad M and ZainAlAbdin, Sham and AlAhmad, Khozama and AlAhmad, Iqbal and AbuRuz, Salah},
  title = {Value of the clinical pharmacist interventions in the application of the American College of Cardiology (ACC/AHA) 2018 guideline for cholesterol management},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0283369}
}
Kostenlos starten →